FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:NDUFB6-ASAP2

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: NDUFB6-ASAP2
FusionPDB ID: 58188
FusionGDB2.0 ID: 58188
HgeneTgene
Gene symbol

NDUFB6

ASAP2

Gene ID

4712

8853

Gene nameNADH:ubiquinone oxidoreductase subunit B6ArfGAP with SH3 domain, ankyrin repeat and PH domain 2
SynonymsB17|CIAMAP2|CENTB3|DDEF2|PAG3|PAP|Pap-alpha|SHAG1
Cytomap

9p21.1

2p25.1|2p24

Type of geneprotein-codingprotein-coding
DescriptionNADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6CI-B17NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDaNADH-ubiquinone oxidoreductase B17 subunitNADH-ubiquinone oxidoreductase beta subunit, 6complex I, mitochondrial respiratory carf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2PYK2 C terminus-associated proteincentaurin, beta 3development and differentiation-enhancing factor 2paxillin-associated protein with ARF GAP activity 3pyk2 C-terminus-associated p
Modification date2020031320200327
UniProtAcc

O95139

Main function of 5'-partner protein: FUNCTION: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.

O43150

Main function of 5'-partner protein: FUNCTION: Activates the small GTPases ARF1, ARF5 and ARF6. Regulates the formation of post-Golgi vesicles and modulates constitutive secretion. Modulates phagocytosis mediated by Fc gamma receptor and ARF6. Modulates PXN recruitment to focal contacts and cell migration. {ECO:0000269|PubMed:10022920, ECO:0000269|PubMed:10749932, ECO:0000269|PubMed:11304556}.
Ensembl transtripts involved in fusion geneENST idsENST00000379847, ENST00000350021, 
ENST00000491413, ENST00000281419, 
ENST00000315273, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score2 X 3 X 1=69 X 10 X 4=360
# samples 311
** MAII scorelog2(3/6*10)=2.32192809488736log2(11/360*10)=-1.71049338280502
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: NDUFB6 [Title/Abstract] AND ASAP2 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: NDUFB6 [Title/Abstract] AND ASAP2 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)NDUFB6(32558908)-ASAP2(9484661), # samples:1
Anticipated loss of major functional domain due to fusion event.NDUFB6-ASAP2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
NDUFB6-ASAP2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr9:32558908/chr2:9484661)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across NDUFB6 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ASAP2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000379847NDUFB6chr932558908-ENST00000281419ASAP2chr29484661+49434201022591829
ENST00000379847NDUFB6chr932558908-ENST00000315273ASAP2chr29484661+48134201022456784

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000379847ENST00000281419NDUFB6chr932558908-ASAP2chr29484661+0.0004108540.99958915
ENST00000379847ENST00000315273NDUFB6chr932558908-ASAP2chr29484661+0.0004605390.9995395

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for NDUFB6-ASAP2

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
NDUFB6chr932558908ASAP2chr29484661420103SEKPYGIVEKKSRIFPDSQIRQSTAY

Top

Potential FusionNeoAntigen Information of NDUFB6-ASAP2 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
NDUFB6-ASAP2_32558908_9484661.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
NDUFB6-ASAP2chr932558908chr29484661420HLA-B27:04SRIFPDSQI0.99950.69671120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B27:05SRIFPDSQI0.99920.7211120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B39:06SRIFPDSQI0.99720.69551120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B39:24SRIFPDSQI0.99710.59751120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B39:01SRIFPDSQI0.99470.85061120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B38:01SRIFPDSQI0.99130.92881120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B38:02SRIFPDSQI0.9910.93031120
NDUFB6-ASAP2chr932558908chr29484661420HLA-A74:09RIFPDSQIR0.98610.81951221
NDUFB6-ASAP2chr932558908chr29484661420HLA-A74:03RIFPDSQIR0.98610.81951221
NDUFB6-ASAP2chr932558908chr29484661420HLA-A74:11RIFPDSQIR0.98610.81951221
NDUFB6-ASAP2chr932558908chr29484661420HLA-A31:06RIFPDSQIR0.98510.64511221
NDUFB6-ASAP2chr932558908chr29484661420HLA-A31:02RIFPDSQIR0.96430.73961221
NDUFB6-ASAP2chr932558908chr29484661420HLA-B15:10SRIFPDSQI0.80440.64261120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B45:01VEKKSRIFP0.71210.7646716
NDUFB6-ASAP2chr932558908chr29484661420HLA-B50:02VEKKSRIFP0.46830.5067716
NDUFB6-ASAP2chr932558908chr29484661420HLA-B41:01VEKKSRIFP0.30650.6268716
NDUFB6-ASAP2chr932558908chr29484661420HLA-B50:01VEKKSRIFP0.13920.6275716
NDUFB6-ASAP2chr932558908chr29484661420HLA-B27:05SRIFPDSQIR0.99980.75521121
NDUFB6-ASAP2chr932558908chr29484661420HLA-A74:03KSRIFPDSQIR0.98770.67341021
NDUFB6-ASAP2chr932558908chr29484661420HLA-A74:11KSRIFPDSQIR0.98770.67341021
NDUFB6-ASAP2chr932558908chr29484661420HLA-A74:09KSRIFPDSQIR0.98770.67341021
NDUFB6-ASAP2chr932558908chr29484661420HLA-B27:14SRIFPDSQI0.99880.59581120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B39:09SRIFPDSQI0.99520.67781120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B39:12SRIFPDSQI0.99410.85981120
NDUFB6-ASAP2chr932558908chr29484661420HLA-C07:95SRIFPDSQI0.99220.71161120
NDUFB6-ASAP2chr932558908chr29484661420HLA-A31:01RIFPDSQIR0.98550.73931221
NDUFB6-ASAP2chr932558908chr29484661420HLA-B27:03SRIFPDSQI0.98130.73161120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B73:01SRIFPDSQI0.9490.78681120
NDUFB6-ASAP2chr932558908chr29484661420HLA-C12:16SRIFPDSQI0.05990.94131120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B27:14SRIFPDSQIR0.99980.70011121
NDUFB6-ASAP2chr932558908chr29484661420HLA-A31:01KSRIFPDSQIR0.99250.591021
NDUFB6-ASAP2chr932558908chr29484661420HLA-B27:10SRIFPDSQI0.99950.80591120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B27:06SRIFPDSQI0.99950.67941120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B27:08SRIFPDSQI0.99920.59991120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B27:09SRIFPDSQI0.99920.70221120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B39:31SRIFPDSQI0.99530.85251120
NDUFB6-ASAP2chr932558908chr29484661420HLA-C07:01SRIFPDSQI0.99340.69041120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B38:05SRIFPDSQI0.99130.92881120
NDUFB6-ASAP2chr932558908chr29484661420HLA-A74:01RIFPDSQIR0.98610.81951221
NDUFB6-ASAP2chr932558908chr29484661420HLA-C06:08SRIFPDSQI0.9050.98421120
NDUFB6-ASAP2chr932558908chr29484661420HLA-C03:02IVEKKSRIF0.87290.9602615
NDUFB6-ASAP2chr932558908chr29484661420HLA-C07:22SRIFPDSQI0.78190.69471120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B50:04VEKKSRIFP0.13920.6275716
NDUFB6-ASAP2chr932558908chr29484661420HLA-B50:05VEKKSRIFP0.13920.6275716
NDUFB6-ASAP2chr932558908chr29484661420HLA-C06:17SRIFPDSQI0.06580.98751120
NDUFB6-ASAP2chr932558908chr29484661420HLA-C06:02SRIFPDSQI0.06580.98751120
NDUFB6-ASAP2chr932558908chr29484661420HLA-B27:10SRIFPDSQIR0.99970.85571121
NDUFB6-ASAP2chr932558908chr29484661420HLA-A74:01KSRIFPDSQIR0.98770.67341021

Top

Potential FusionNeoAntigen Information of NDUFB6-ASAP2 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
NDUFB6-ASAP2_32558908_9484661.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0301KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0301KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0301EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0301SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0303KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0303KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0305KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0305KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0307KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0307KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0307EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0307SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0310KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0310KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0310EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0313KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0313KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0313EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0313SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0315KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0315KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0315EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0315SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0318KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0318KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0318EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0318SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0320KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0320KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0320EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0320SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0322KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0322KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0322EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0322SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0324KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0324KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0324EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0326KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0326KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0326EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0326SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0328KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0328KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0328EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0328SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0330KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0330KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0330EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0330SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0332KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0332KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0332EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0332SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0334KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0334KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0334EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0334SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0336KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0336KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0336EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0336SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0340KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0340KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0342KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0342KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0342EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0342SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0344KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0344KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0344EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0344SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0346KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0346KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0346EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0346SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0348KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0348KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0348EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0348SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0350KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0350KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0350EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0350SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0352KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0352KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0352EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0352SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0354KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0354KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0354EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0354SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0466KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0466KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0819PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-0834PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1102PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1102KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1107KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1107KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1107EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1107SRIFPDSQIRQSTAY1126
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1108EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1111EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1114EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1114KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1114SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1114PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1116PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1116KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1119EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1119SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1120EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1120KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1120SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1120PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1121PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1121KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1131EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1131SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1136PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1145EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1148PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1155PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1164EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1164SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1165PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1165KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1168EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1168SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1168KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1170PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1170KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1172EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1173EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1173SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1179KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1179KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1179EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1182EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1182SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1186EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1186KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1186SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1186PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1204PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1208PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1208KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1209PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1219PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1301PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1301KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1302EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1302KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1302SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1302PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1304PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1304KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1308PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1315PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1315KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1316EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1316KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1316SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1316PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1317PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1317KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1317EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1319PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1319KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1320PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1322PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1322KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1323EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1323KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1323SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1323PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1327PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1329EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1329SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1329KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1331PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1331KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1331EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1334EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1334KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1334SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1334PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1335PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1335KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1336EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1336SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1336KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1337KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1339EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1339KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1339SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1339PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1341EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1341SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1341KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1343PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1343KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1351PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1351KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1352PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1352KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1353PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1353KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1354PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1354KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1354EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1356EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1357PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1357KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1359PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1359KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1361PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1363EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1364PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1364KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1367PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1368PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1368KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1369PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1369KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1370PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1372PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1373EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1373KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1373SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1373PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1374EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1374KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1374SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1374PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1378PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1379PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1379KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1380PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1380KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1382EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1382SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1383PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1383KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1384PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1385EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1386EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1386SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1387PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1387KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1391PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1391KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1392PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1392KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1393PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1393KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1394KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1394KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1396EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1396KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1396SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1397EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1397KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1397SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1397PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1398PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1398KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1399EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1399KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1399SEKPYGIVEKKSRIF015
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1399PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1403EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1409KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1416PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1416KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1419KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1419KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1421KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1421KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1424EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1430EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1440EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1442EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1447KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1467EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1476KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1476KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1476EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1477EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1479KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1479KKSRIFPDSQIRQST924
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1479EKKSRIFPDSQIRQS823
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1480KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1489EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1498EKPYGIVEKKSRIFP116
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1510PYGIVEKKSRIFPDS318
NDUFB6-ASAP2chr932558908chr29484661420DRB1-1510KPYGIVEKKSRIFPD217
NDUFB6-ASAP2chr932558908chr29484661420DRB3-0114KSRIFPDSQIRQSTA1025
NDUFB6-ASAP2chr932558908chr29484661420DRB3-0204KSRIFPDSQIRQSTA1025

Top

Fusion breakpoint peptide structures of NDUFB6-ASAP2

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
4044IVEKKSRIFPDSQINDUFB6ASAP2chr932558908chr29484661420

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of NDUFB6-ASAP2

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN4044IVEKKSRIFPDSQI-6.15238-6.26578
HLA-B14:023BVN4044IVEKKSRIFPDSQI-5.35203-6.38733
HLA-B52:013W394044IVEKKSRIFPDSQI-5.804-6.8393
HLA-B52:013W394044IVEKKSRIFPDSQI-5.45277-5.56617
HLA-A11:014UQ24044IVEKKSRIFPDSQI-8.28119-9.31649
HLA-A24:025HGA4044IVEKKSRIFPDSQI-9.93626-10.0497
HLA-A24:025HGA4044IVEKKSRIFPDSQI-5.67154-6.70684
HLA-B27:056PYJ4044IVEKKSRIFPDSQI-4.30966-5.34496
HLA-B44:053DX84044IVEKKSRIFPDSQI-7.17842-7.29182
HLA-B44:053DX84044IVEKKSRIFPDSQI-4.14208-5.17738
HLA-A02:016TDR4044IVEKKSRIFPDSQI-5.17192-5.28532

Top

Vaccine Design for the FusionNeoAntigens of NDUFB6-ASAP2

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
NDUFB6-ASAP2chr932558908chr294846611021KSRIFPDSQIRATATTCCCTGACTCCCAAATTCGTCAGAGCACA
NDUFB6-ASAP2chr932558908chr294846611120SRIFPDSQITTCCCTGACTCCCAAATTCGTCAGAGC
NDUFB6-ASAP2chr932558908chr294846611121SRIFPDSQIRTTCCCTGACTCCCAAATTCGTCAGAGCACA
NDUFB6-ASAP2chr932558908chr294846611221RIFPDSQIRCCTGACTCCCAAATTCGTCAGAGCACA
NDUFB6-ASAP2chr932558908chr29484661615IVEKKSRIFAAGAAGTCCAGAATATTCCCTGACTCC
NDUFB6-ASAP2chr932558908chr29484661716VEKKSRIFPAAGTCCAGAATATTCCCTGACTCCCAA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
NDUFB6-ASAP2chr932558908chr29484661015SEKPYGIVEKKSRIFCCATATGGCATAGTTGAAAAGAAGTCCAGAATATTCCCTGACTCC
NDUFB6-ASAP2chr932558908chr29484661116EKPYGIVEKKSRIFPTATGGCATAGTTGAAAAGAAGTCCAGAATATTCCCTGACTCCCAA
NDUFB6-ASAP2chr932558908chr294846611025KSRIFPDSQIRQSTAATATTCCCTGACTCCCAAATTCGTCAGAGCACAGCTTATAGCTTA
NDUFB6-ASAP2chr932558908chr294846611126SRIFPDSQIRQSTAYTTCCCTGACTCCCAAATTCGTCAGAGCACAGCTTATAGCTTACAT
NDUFB6-ASAP2chr932558908chr29484661217KPYGIVEKKSRIFPDGGCATAGTTGAAAAGAAGTCCAGAATATTCCCTGACTCCCAAATT
NDUFB6-ASAP2chr932558908chr29484661318PYGIVEKKSRIFPDSATAGTTGAAAAGAAGTCCAGAATATTCCCTGACTCCCAAATTCGT
NDUFB6-ASAP2chr932558908chr29484661823EKKSRIFPDSQIRQSTCCAGAATATTCCCTGACTCCCAAATTCGTCAGAGCACAGCTTAT
NDUFB6-ASAP2chr932558908chr29484661924KKSRIFPDSQIRQSTAGAATATTCCCTGACTCCCAAATTCGTCAGAGCACAGCTTATAGC

Top

Information of the samples that have these potential fusion neoantigens of NDUFB6-ASAP2

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADNDUFB6-ASAP2chr932558908ENST00000379847chr29484661ENST00000281419TCGA-CG-5724-01A

Top

Potential target of CAR-T therapy development for NDUFB6-ASAP2

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneNDUFB6chr9:32558908chr2:9484661ENST00000379847-3468_86106129.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to NDUFB6-ASAP2

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to NDUFB6-ASAP2

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource